Molecular Genetics and Metabolism Reports (Sep 2021)

Non-functional alternative splicing caused by a Latino pathogenic variant in a case of PMM2-CDG

  • C.A. González-Domínguez,
  • C.E. Villarroel,
  • M. Rodríguez-Morales,
  • S. Manrique-Hernández,
  • A. González-Jaimes,
  • F. Olvera-Rodriguez,
  • K. Beutelspacher,
  • C. Molina-Garay,
  • K. Carrillo-Sánchez,
  • L.L. Flores-Lagunes,
  • M. Jiménez-Olivares,
  • A. Muñoz-Rivas,
  • M.E. Cruz-Muñoz,
  • H.M. Mora-Montes,
  • R. Salinas-Marín,
  • C. Alaez-Verson,
  • I. Martínez-Duncker

Journal volume & issue
Vol. 28
p. 100781

Abstract

Read online

We report on a Mexican mestizo with a multisystemic syndrome including neurological involvement and a type I serum transferrin isoelectric focusing (Tf IEF) pattern. Diagnosis of PMM2-CDG was obtained by clinical exome sequencing (CES) that revealed compound heterozygous variants in PMM2, the encoding gene for the phosphomannomutase 2 (PMM2). This enzyme catalyzes the conversion of mannose-6-P to mannose-1-P required for the synthesis of GDP-Man and Dol-P-Man, donor substrates for glycosylation reactions. The identified variants were c.422G>A (R141H) and c.178G>T, the former being the most frequent PMM2 pathogenic mutation and the latter a previously uncharacterized variant restricted to the Latino population with conflicting interpretations of pathogenicity and that we here report causes leaky non-functional alternative splicing (p.V60Cfs*3).